We look forward to talking more with you during our Virtual Kick-Off at 6 p.m. Wednesday, Nov. 11.
Structural
A cortical-cancellous structural allograft for ACDF with the high quality and proven clinical success you depend on from the global leader in fusion and cellular therapies
.png)
ARTHROFLEX®
Exceptional Handling.
Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology. Matracell removes a minimum of 97% of donor DNA1, allowing for rapid cellular infiltration and re-vascularization. Dermacell AWM is terminally sterilized, ready to use without refrigeration or re-hydration.
Director of Orthopaedic Research at Jersey City Medical Center, Barnabas Health
Use of ViviGen® Cellular Bone Allograft in Orthopaedic Trauma.
Do We Even Need Iliac Crest Anymore?
Hear from three surgeons on their experience with using ViviGen in their patients.
Dr. Joseph S. Park, University of Virginia
Dr. John Hall, Flagstaff Bone and Joint
ViviGen is the first cellular allograft to focus on recovering, processing, and protecting viable, lineage committed bone cells. It is comprised of viable, cryopreserved corticocancellous bone matrix and demineralized bone. These three components of ViviGen provide the properties necessary for bone repair that include osteoinductive signals, osteoconductive bone scaffolds, and osteogenic cells.
Dr. Jeffrey Marschall, University of Iowa Hospitals and Clinics
Dr. Jeffrey Marschall on his use of ViviGen in complex CMF procedures
